+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID05929495

Phase 2, Open-label Study of Metformin with Temozolomide in Adults with IDH-Wildtype Glioblastoma

Led by University of Milano Bicocca · Updated on 2025-07-25

25

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of metformin as an additional treatment alongside temozolomide TMZ for patients with glioblastoma GBM, a highly aggressive type of brain tumor classified as IDH-wildtype. This phase II, single-center, single-arm clinical trial aims to assess the biological activity and effects of combining metformin with TMZ in treating GBM. The study is sponsored by the University of Milano Bicocca and is expected to last about 32 months with 25 patients enrolled. Participants will start by taking 1 gram per day of metformin orally in two 500 mg doses for the first two weeks, then increase to 2 grams per day for a total of six weeks. After six weeks, metformin alone will be taken for four weeks. Following this initial period, participants will continue treatment with the standard or partial Stupp protocol radiotherapy plus TMZ combined with metformin continuously until 58 weeks from treatment start, covering the entire enrollment period. During the study, patients will undergo assessments including the progression-free survival PFS measured at six months after treatment start, quality of life questionnaires EORTC QLQ-C30, cognitive function tests MMSE, and safety and tolerability evaluations throughout the 32-month study duration. Additional analyses such as plasma metabolite measurements, proteomic and gene expression evaluations, and correlations between clinical response and laboratory findings will be conducted. Participants will be closely monitored for treatment effects and safety during the entire study period.

CONDITIONS

Brief Title

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Research Team

M

Manuela Caroli, Dott.ssa

R

Rosa Maria Moresco, Dott.ssa

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here